Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Preoperative HER2 Targeting and Endocrine Therapy in Postmenopausal Women With HER2 and HR Positive Breast Cancer

NCT02214004 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT02214004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02214004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Preoperative HER2 Targeting and Endocrine Therapy in Postmenopausal Women With HER2 and HR Positive Breast Cancer
Lead sponsor
Gangnam Severance Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2015
Completion date
June 30, 2019
Enrollment
132 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer